Over-expression of Toll-like receptors and their ligands in small-for-size graft

Hepatology Research

Volumn 40, Issue 3, 2010, Pages 318-329

  Jiang, Weiwei ^a   Hu, Mingzheng ^b   Rao, Jianhua ^b   Xu, Xiaoqun ^a   Wang, Xuehao ^b   Kong, Lianbao ^a  

^a CHILDREN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Endotoxin; Heat shock protein; Liver transplantation; Small for size graft; Toll like receptor

Indexed keywords

CD14 ANTIGEN; ENDOTOXIN; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HEPATITIS; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; MOUSE; NONHUMAN; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; REPERFUSION;

EID: 77954370178     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2009.00603.x     Document Type: Article

References (51)

1. Ito T, Kiuchi T, Yamamoto H. Changes in portal venous pressure in the early phase after living-donor liver transplantation: Pathogenesis and clinical implications. Transplantation 2003, 75:1313-17.
2. Man K, Fan ST, Lo CM. Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression. Ann Surg 2003, 237:256-64.
3. Liang TB, Man K, Kin-Wah Lee T. Distinct intragraft response pattern in relation to graft size in liver transplantation. Transplantation 2003, 75:673-8.
4. Shiraishi M, Csete ME, Yasunaga C. Regeneration-induced accelerated rejection in reduced-size liver grafts. Transplantation 1994, 57:336-40.
5. Yang ZF, Ho DW, Chu AC. Linking inflammation to acute rejection in small-for-size liver allografts: the potential role of early macrophage activation. Am J Transplant 2004, 4:196-209.
6. Lin T, Zhou W, Sacks SH. The role of complement and Toll-like receptors in organ transplantation. Transpl Int 2007, 20:481-9.
7. Muzio M, Mantovani A. The Toll receptor family. Allergy 2001, 56:103-8.
8. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003, 1:335-76.
9. Yao XM, Chen H, Li Y. Protective effect of bicyclol on liver injury induced by hepatic warm ischemia/reperfusion in rats. Hepatol Res 2009, Epub ahead of print
10. Andreakos E, Foxwell B, Feldmann M. Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation? Immunol Rev 2004, 202:250-65.
11. John B, Klein I, Crispe IN. Immune role of hepatic TLR-4 revealed by orthotopic mouse liver transplantation. Hepatology 2007, 45:178-86.
12. Zhai Y, Shen XD, O'Connell R. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 2004, 173:7115-19.
13. Tsoulfas G, Takahashi Y, Ganster RW. Activation of the lipopolysaccharide signaling pathway in hepatic transplantation preservation injury. Transplantation 2002, 74:7-13.
14. Sieling PA, Modlin RL. Activation of toll-like receptors by microbial lipoproteins. Scand J Infect Dis 2001, 33:97-100.
15. Tsan MF, Gao B. Endogenous ligands of Toll-like receptors. J Leukoc Biol 2004, 76:514-19.
16. Termeer C, Benedix F, Sleeman J. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002, 195:99-111.
17. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 2001, 167:2887-94.
18. Shimazu R, Akashi S, Ogata H. MD-2 a molecule that confers LPS responsiveness on toll-like receptor 4. J Exp Med 1999, 189:1777-82.
19. Fearns C, Kravchenko V, Ulevitch RJ. Murine CD14 gene expression in vivo: extramyeloid synthesis and regulation by lipopolysaccharide. J Exp Med 1995, 181:857-66.
20. Kamada N, Calne RY. A surgical experience with five hundred thirty liver transplants in the rat. Surg 1983, 93:64.
21. Man K, Lo CM, Ng IO. Liver transplantation in rats using small-for-size grafts: a study of hemodynamic and morphological changes. Arch Surg 2001, 136:280-5.
22. Beutler B, Rietschel ET. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 2003, 3:169-76.
23. Buss H, Chan TP, Sluis KB. Protein carbonyl measurement by a sensitive ELISA method. Free Radic Biol Med 1997, 23:361-6.
24. Kirschning CJ, Wesche H, Merrill Ayres T. Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med 1998, 188:2091-7.
25. Miyata T, Yokoyama I, Todo S. Endotoxaemia, pulmonary complications, and thrombocytopenia in liver transplantation. Lancet 1989, 2:189-91.
26. Zhai Y, Qiao B, Shen XD. Evidence for the pivotal role of endogenous toll-like receptor 4 ligands in liver ischemia and reperfusion injury. Transplantation 2008, 85:1016-22.
27. Land WG. The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation. Transplantation 2005, 79:505-14.
28. Chen K, Huang J, Gong W. Toll-like receptors in inflammation, infection and cancer. Int Immunopharmacol 2007, 7:1271-85.
29. Land W. Allograft injury mediated by reactive oxygen species: From conserved proteins of drosophila to acute and chronic rejection of human transplants. Part II: Role of reactive oxygen species in the induction of the heat shock protein as a regulator of innate immunity. Transplant Rev 2003, 17:31-44.
30. Takeda K, Akira S. TLR signaling pathways. Semin Immunol 2004, 16:329.
31. Froy O. Regulation of mammalian defensin expression by Toll-like receptor-dependent and independent signalling pathways. Cell Microbiol 2005, 7:1387-97.
32. Verheij M, Bose R, Lin XH. Requirement for ceramide-initiated SAPK/JNK signaling in stress-induced apoptosis. Nature 1996, 380:75-9.
33. Seki E, Brenner DA. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 2008, 48:322-35.
34. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997, 336:1066-71.
35. Braudeau C, Ashton-Chess J, Giral M. Contrasted blood and intragraft toll-like receptor 4 mRNA profiles in operational tolerance versus chronic rejection in kidney transplant recipients. Transplantation 2008, 86:130-6.
36. Ducloux D, Deschamps M, Yannaraki M. Relevance of Toll-like receptor-4 polymorphisms in renal transplantation. Kidney Int 2005, 67:2454-61.
37. Palmer SM, Burch LH, Davis RD. The role of innate immunity in acute allograft rejection after lung transplantation. Am J Respir Crit Care Med 2003, 168:628.
38. Morel PA, Feili-Hariri M, Coates PT. Dendritic cells, T cell tolerance and therapy of adverse immune reactions. Clin Exp Immunol 2003, 133:1-10.
39. Gad M, Claesson MH, Pedersen AE. Dendritic cells in peripheral tolerance and immunity. APMIS 2003, 111:766-75.
40. Sheng KC, Kalkanidis M, Pouniotis DS. The adjuvanticity of a mannosylated antigen reveals TLR4 functionality essential for subset specialization and functional maturation of mouse dendritic cells. J Immunol 2008, 181:2455-64.
41. Granucci F, Zanoni I. Role of Toll like receptor-activated dendritic cells in the development of autoimmunity. Front Biosci 2008, 13:4817-26.
42. Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 2007, 7:179-90.
43. Pasterkamp G, Van Keulen JK, De Kleijn DP. Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease. Eur J Clin Invest 2004, 34:328-34.
44. Schnare M, Barton GM, Holt AC. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001, 2:947-50.
45. Goldstein DR, Tesar BM, Akira S. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J Clin Invest 2003, 111:1571-8.
46. Björkbacka H, Kunjathoor VV, Moore KJ. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med 2004, 10:416-21.
47. Michelsen KS, Wong MH, Shah PK. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA 2004, 101:10679-84.
48. Edfeldt K, Swedenborg J, Hansson GK. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 2002, 105:1158-61.
49. Xu XH, Shah PK, Faure E. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 2001, 104:3103-8.
50. Yan ZQ, Hansson GK. Innate immunity, macrophage activation, and atherosclerosis. Immunol Rev 2007, 219:187-203.
51. Shinohara M, Hirata K, Yamashita T. Local overexpression of Toll-like receptors at the vessel wall induces atherosclerotic lesion formation synergism of TLR2 and TLR4. Arterioscler Thromb Vasc Biol 2007, 27:2384-91.